Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Conference on Hematology and Thrombosis Research (ICHTR-26) provides an educational platform focused on advances in hematology, coagulation, and thrombosis research. The course explores blood disorders, thrombotic and bleeding conditions, diagnostic approaches, anticoagulation, and emerging treatment strategies. Participants can gain insights into current research, clinical developments, and innovations relevant to the diagnosis and management of hematological and thrombotic disorders.
The International Conference on Hematology and Thrombosis Research (ICHTR-26) brings together hematologists, clinicians, researchers, scientists, and healthcare professionals to explore recent advances in hematology and thrombosis research. The conference focuses on developments in blood disorders, coagulation, thrombosis, and emerging approaches to diagnosis and treatment. Participants can explore current research findings, diagnostic techniques, therapeutic strategies, and innovations in the management of hematological and thrombotic conditions. The program provides a platform for sharing clinical experiences, scientific discoveries, and developments in laboratory and translational research. Discussions may cover bleeding disorders, venous and arterial thrombosis, anticoagulation, platelet disorders, hematologic malignancies, and advances in personalized care. The conference encourages interdisciplinary collaboration and knowledge exchange among professionals working across hematology, vascular medicine, laboratory science, and related specialties. ICHTR-26 supports continued professional development by highlighting evolving research and clinical approaches in hematology, coagulation, and thrombosis.
Modern approaches to the diagnosis and management of deep vein thrombosis and pulmonary embolism.
Advances in anticoagulant and antithrombotic therapies and strategies for optimizing treatment.
Diagnosis and management of various inherited and acquired thrombophilias.
Recognition and treatment of HIT and its associated thrombotic complications.
Exploring the complex relationship between cancer, hematological disorders, and thrombosis.
Thrombosis management in pregnancy, pediatric patients, and surgical patients.
Advances in laboratory testing, platelet function testing, and molecular diagnostics.
New developments in personalized and precision approaches to thrombosis and hematological disease management.
This conference is accredited by the Saudi Commission for Health Specialties (SCFHS) for 6 CME hours.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow